#glp-1-receptor-agonists

[ follow ]
#weight-loss
Public health
fromScienceDaily
2 months ago

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle

GLP-1 receptor agonists help lower blood sugar and aid weight loss by reducing fat mass more than muscle mass.
Medicine
fromwww.theguardian.com
11 months ago

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
Cancer
fromwww.theguardian.com
1 week ago

Weight-loss jabs could halve risk of obesity-related cancers, study finds

Weight-loss injections significantly reduce the risk of obesity-related cancers, suggesting a new approach to preventive medicine.
Wearables
fromNew York Post
1 month ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
Public health
fromScienceDaily
2 months ago

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle

GLP-1 receptor agonists help lower blood sugar and aid weight loss by reducing fat mass more than muscle mass.
Medicine
fromwww.theguardian.com
11 months ago

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
Cancer
fromwww.theguardian.com
1 week ago

Weight-loss jabs could halve risk of obesity-related cancers, study finds

Weight-loss injections significantly reduce the risk of obesity-related cancers, suggesting a new approach to preventive medicine.
Wearables
fromNew York Post
1 month ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
more#weight-loss
#obesity-treatment
Alternative medicine
fromenglish.elpais.com
2 weeks ago

The Ozempic universe expands: These drugs also treat fatty liver disease

Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.
US news
fromBoston.com
3 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
Alternative medicine
fromenglish.elpais.com
2 weeks ago

The Ozempic universe expands: These drugs also treat fatty liver disease

Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.
US news
fromBoston.com
3 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
more#obesity-treatment
Mental health
fromPsychology Today
2 months ago

The Psychology of Addiction and Obesity: New Treatments

Addiction and obesity share neurological pathways, reinforcing compulsive behaviors.
GLP-1 receptor agonists may help regulate both appetite and addictive cravings.
Emerging compounds, such as MEAI, are being studied for its potential in addiction treatment.
A holistic approach combining therapy, medication, and new research offers hope.
[ Load more ]